Access to Innovation. To the extent that health care authorities in a Party operate or maintain procedures for listing pharmaceutical products or medical devices, for indications entitled to reimbursement, or for setting the amount of reimbursement or any measures related to pricing1 for pharmaceutical products or medical devices under health care programmes they operate, that Party shall:
Appears in 2 contracts
Access to Innovation. To the extent that health care authorities in a Party operate or maintain procedures for listing pharmaceutical products or medical devices, for indications entitled to reimbursement, or for setting the amount of reimbursement or any measures related to pricing1 xxxxxxx00 for pharmaceutical products or medical devices under health care programmes they operate, that Party shall:
Appears in 2 contracts
Samples: data.consilium.europa.eu, www.eumonitor.eu
